Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer

BACKGROUND: With the essential role of interleukin-1 signaling in cancer-related inflammation, IL-1R1, the main receptor for both IL-1α and IL-1β, demonstrated therapeutic potential in several types of cancer, which has been put into clinical trials. However, the expression profile and critical role...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Puran, Gu, Yun, Fang, Hanji, Cao, Yifan, Wang, Jieti, Liu, Hao, Zhang, Heng, Li, He, He, Hongyong, Li, Ruochen, Lin, Chao, Xu, Jiejie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811600/
https://www.ncbi.nlm.nih.gov/pubmed/35110359
http://dx.doi.org/10.1136/jitc-2021-004047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811600/
https://www.ncbi.nlm.nih.gov/pubmed/35110359
http://dx.doi.org/10.1136/jitc-2021-004047

Ejemplares similares